Journal of Biomedicine and Biotechnology

Volume 2012 (2012), Article ID 902351, 7 pages

doi:10.1155/2012/902351

Research Article

Treatment with Aqueous Extract from Croton cajucara Benth Reduces Hepatic Oxidative Stress in Streptozotocin-Diabetic Rats

Graziella Ramos Rodrigues,1,2 Fábio Cangeri Di Naso,2,3 Marilene Porawski,2,4 Éder Marcolin,⁴ Nélson Alexandre Kretzmann,⁴ Alexandre de Barros Falcão Ferraz,⁵ Marc Francois Richter,5,6 Cláudio Augusto Marroni,⁴ and Norma Possa Marroni1,2,5

¹Post-Graduation Program in Medical Sciences, Medical School, Federal University of Rio Grande do Sul (UFRGS), 90035-903 Porto Alegre, RS, Brazil

²Research Center, Hospital de Clínicas de Porto Alegre, Federal University of Rio Grande do Sul (UFRGS), 90035-903 Porto Alegre, RS, Brazil

³Physiotherapy Course, Catholic University of Pelotas (UCPEL), Porto Alegre, RS, Brazil

⁴Federal University of Health Sciences of Porto Alegre (UFCSPA), 90050-170 Porto Alegre, RS, Brazil

⁵Lutheran University of Brazil, 92425-900 Canoas, RS, Brazil

⁶State University of Rio Grande do Sul Porto Alegre, 90010-191 Porto Alegre, RS, Brazil

Received 12 March 2012; Revised 1 May 2012; Accepted 7 May 2012

Academic Editor: Sandro Massao Hirabara

Copyright © 2012 Graziella Ramos Rodrigues et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Croton cajucara Benth is a plant found in Amazonia, Brazil and the bark and leaf infusion of this plant have been popularly used to treat diabetes and hepatic disorders. The present study was designed to evaluate the oxidative stress as well as the therapeutic effect of Croton cajucara Benth (1.5 mL of the C. cajucara extract i.g.) in rats with streptozotocin-induced diabetes. Croton cajucara Benth was tested as an aqueous extract for its phytochemical composition, and its antioxidant activity in vitro was also evaluated. Lipid peroxidation and superoxide dismutase, catalase, and glutathione reductase activities were measured in the hepatic tissue, as well as the presence activation of p65 (NF-κB), through western blot. Phytochemical screening of Croton cajucara Benth detected the presence of flavonoids, coumarins and alkaloids. The extract exhibited a significant antioxidant activity in the DPPH-scavenging and the hypoxanthine/xanthine oxidase assays. Liver lipid peroxidation increased in diabetic animals followed by a reduction in the Croton-cajucara-Benth-treated group. There was activation of p65 nuclear expression in the diabetic animals, which was attenuated in the animals receiving the Croton cajucara Benth aqueous extract. The liver tissue in diabetic rats showed oxidative alterations related to the streptozotocin treatment. In conclusion the Croton cajucara Benth aqueus extract treatment effectively reduced the oxidative stress and contributed to tissue recovery.

1. Introduction

Diabetes mellitus (DM) is a group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin secretion, insulin action, or both. The chronic hyperglycemia of diabetes is associated with long-term damage, dysfunction, and failure of various organs, especially the eyes, kidneys, nerves, heart, and blood vessels [1]. There are convincing experimental and clinical pieces of evidences that the generation of reactive oxygen species (ROS) is increased in both types of diabetes and that the onset of diabetes is closely associated with oxidative stress [2]. Free radicals are formed disproportionately in diabetes by glucose oxidation, nonenzymatic glycation of proteins, and the subsequent oxidative degradation of glycated proteins [3].

Oxidative stress, the prevalence of oxidant factors over antioxidant mechanisms, plays a central role in the pathogenesis and progression of diabetes and its complications [4]. Enhanced formation of oxygen free radicals occurs in tissues during hyperglycemia [5]. The hyperglycemia can also activate transcription factors, such as nuclear factor NF-κB. This factor regulates the expression of a large number of genes including those who have deeper connection to the complications of diabetes [6]. Hyperglycemia also favors, through the activation of NF-κB, an increased expression of inducible nitric oxide synthase (iNOS), which is accompanied by increased generation of nitric oxide [7].

Traditional medicines and extracts from medicinal plants have been extensively used as alternative medicine for better control and management of DM [8]. Croton cajucara Benth (C. cajucara), commonly known as Sacaca, is a shrubby plant found in Amazonia, Brazil [9]. The bark and leaf infusions of this plant have been popularly used to treat diabetes, diarrhea, malaria, fever, gastrointestinal, renal, and hepatic disorders, as well as in the control of high levels of cholesterol [10, 11]. Antioxidant effects of C. cajucara leaf extracts was investigated both in vitro and in vivo models. Leaf extracts showed radical inhibitory scavenging activity against the stable radical DPPH and reduced oxidative stress in animals treated with paraquat [12].

The liver is the main organ of oxidative and detoxifying processes. In many diseases, biomarkers stress oxidative are elevated in the liver at an early stage [13]. Thus, the present investigation was carried out in order to study the possible antioxidant effect and the expression of NF-κB of C. cajucara aqueous extract in streptozotocin-diabetic rats.

2. Materials and Methods

2.1. Plant Material and Preparation of C. cajucara Bark Aqueous Extract

Bark fragments of C. cajucara were collected in Amazônia-Santarém, Brazil. A voucher specimen (number 247) identifiedby Nelson A. Rosa was deposited in the IAN Herbarium(Belém, PA, Brazil).

The bark (5 g) was ground and mixed with boiling water (100 mL) to provide a 5% aqueous extract. After 10 minutes, the mixture was filtered with filter paper and the extract was administered to the rats. After cooling and filtering, the extracts were frozen and concentrated by lyophilization for five days overnight.

2.2. Phytochemical Screening

The phytochemical analysis (flavonoids, tannins, anthraquinones, alkaloids, saponins, coumarins, and cardiac glycosides) of C. cajucara bark was carried out according to the methods described by Harbone [14]. The thin layer chromatography analyses were performed following systems and developers indicated by Wagner and Bladt [15].

2.3. In Vitro Test for Antioxidant Activity of Bark Aqueous Extract

2.3.1. Hypoxanthine/Xanthine Oxidase Assay

The method employed to assay the hydroxyl radical () scavenging ability of C. cajucara aqueous extract or infusions was based on the method developed by Owen et al. [16]. Briefly, C. cajucara aqueous extract or infusions were dissolved in the assay buffer (hypoxanthine, Fe (III), EDTA, and salicylic acid) at a concentration of 2.0 mg/mL and diluted appropriately (in triplicate) in assay buffer to a final volume of 1.0 mL, giving a range of 0.1–2.0 mg/mL for extract and volumes of 10–200 L of aqueous infusions of C. cajucara bark. A 5 L aliquot of xanthine oxidase dissolved in 3.2 M (NH₄)₂SO₄ was added to initiate the reaction. The sample tubes were incubated for 3 h at 37°C, and the reaction stopped afterwards by adding 10 L of HCl. A 30 L aliquot of the reaction mixture was analyzed by HPLC under chromatographic conditions as described by Owen et al. [17, 18] Chromatographic analysis was done using a gradient based on methanol/water/acetic acid with a BondaPak C18 reverse phase column (Waters) and detection at 325 nm. The HPLC equipment had a 2695 separation module (Waters) and a UV detector 2487 (Waters). Hydroxylation of salicylic acid and hypoxanthine was monitored at and nm, respectively. The amount of dihydroxyphenols (2,5-dihydroxybenzoic acid and 2,3-dihydroxibenzoic acid) (2,5-DHBA and 2,3-DHBA) produced by () attack on salicylic acid was determined from standard curves prepared with the respective pure dihydroxyphenols.

2.3.2. DPPH Scavenging Assay

Scavenging of the DPPH free radical was measured using a modified Yamaguchi et al. [19] method in which C. cajucara aqueous extract or C. cajucara bark infusions were added to Tris-HCl (100 mM) buffer, pH 7.0, containing 250 mM DPPH dissolved in methanol. At least six different dilutions of C. cajucara aqueous extract or C. cajucara bark infusions were tested and allowed to stand for 20 min in the dark, before absorbance was measured at 517 nm using a Shimadzu spectrophotometer model UV-1602PC (Kyoto, Japan). The experiment was conducted in triplicate. Antioxidant activity was expressed as IC₅₀ (inhibitory concentration in g/mL of samples or positive controls necessary to reduce the absorbance of DPPH by 50%, as compared to the negative control). The lower the IC₅₀, the higher is the antioxidant activity.

2.3.3. Animals and Experimental Protocol

The experimental protocol used complied with the norms established by the Ethical and Health Research Committee of the Group of Research and Postgraduate Studies of the Hospital de Clínicas of Porto Alegre as well as with the Principles for Research Involving Animals. Only male Wistar rats were used, obtained from the breeding colony of the Instituto de Ciências Básicas da Saúde da Universidade Federal do Rio Grande do Sul (UFRGS). The mean weight of animals at the start of the study was 200–300 grams. They were kept under a 12 : 12 hours light/dark cycle (light from 7 am to 7 pm) in a temperature-controlled environment (°C). The rats were randomly divided into 6 groups. In 3 groups, diabetes was induced by a single intraperitoneal (i.p) injection of streptozotocin (70 mg/kg body weight; Sigma Chemical) in freshly prepared 10 mmol/L sodium citrate, pH 4,5. Five days after the STZ injection, plasma glucose concentration was measured using retro orbital blood samples obtained from rats after overnight food deprivation. A plasma glucose level > 250 mg/dL was considered indicative of diabetes. The experimental groups comprised the following: (i) normal control group (CO: ) that received 1,5 mL of distilled water administered intragastrically (i.g.); (ii) group treated with C. cajucara for 5 days (CO5D: ) 1,5 mL of the C. cajucara extract i.g. during the last 5 days before being killed; (iii) group treated with C. cajucara for 20 days (CO20D: ) 1,5 mL of the C. cajucara extract i.g. for 20 days before being killed; (iv) diabetic group (DM: ) 1,5 mL of distilled water i.g.; (v) diabetic group treated with C. cajucara for 5 days (DM5D: ), 1,5 mL of the C. cajucara extract i.g. during the last 5 days before killed; (vi) diabetic group treated with C. cajucara for 20 days (DM20D: ), 1,5 mL of the C. cajucara extract i.g. for 20 days before being killed.

2.3.4. Biochemical Analyses of Oxidative Stress and Antioxidant Assay

The livers were homogenized with 9 mL of phosphate buffer (KCL 140 mM, phosphate 20 mM, pH 7.4) per gram of tissue. The protein concentration in these liver homogenates was determined using a standard solution of bovine albumin according to Lowry et al. [20]. Hepatics lipoperoxidation was determined by the method of thiobarbituric acid reactive substances (TBA-RS) [21]. Superoxide dismutase (SOD) activity in the liver tissue was determined using a technique based on the inhibition of adrenochrome formation in epinephrine autoxidation [22]. Catalase (CAT) activity in the liver tissue was determined as described elsewhere [23]. For Glutathione reductase (GSH) measurement, it was made according to adapted method by Kolberg et al. [24].

2.3.5. Western Blot for p65 NF-κB Subunit

75 g of nuclear extracts, prepared as described by Gutiérrez et al. [25], was loaded on an SDS/PAGE gel (10%), electroblotted, and p65 protein was detected using specific polyclonal antibodies (65 kDa) (NF-κB p65 (C22B4) Rabbit mAb-cell signaling). Bound primary antibody was detected, HRP—with Anti-rabbit IgG antibody Cell Signaling and blots were developed using an enhanced chemiluminescence detection system (ECL kit, Amersham Pharmacia, Uppsala, Sweden). The density of the specific bands was quantified with an imaging densitometer Software (Scion Image, Maryland, MA).

2.4. Statistical Analysis

The results were expressed as mean values ± SEM. The data were compared by analysis of variance (ANOVA); when the analysis indicated the presence of a significant difference, the means were compared with the Student Newman Keuls test. The level of significance used was .

3. Results

3.1. Phytochemical Analyses

Phytochemical analyses of C. cajucara indicated the presence of flavonoids, coumarins, and alkaloids. Other secondary metabolites such as saponins, anthraquinones, cardiac glycosides, fenolic acids, and tannins were not detected.

3.2. Hypoxanthine/Xanthine Oxidase In Vitro Assay

The in vitro antioxidant activity of the extract was determined by monitoring the production of hydroxyl benzoic acids (DHBA) as a product of the hydroxyl radical attack on salicylic acid in the hipoxanthine-xanthine oxidase assay. The reduction of total oxidation products as a function of the concentration of C. cajucara added to the assay is shown in Figure 1. The aqueous extract (IC₅₀ = 1.61 mg/mL) displayed a pronounced in vitro antioxidant capacity in a dose-dependent manner, reducing the formation of both DHBA species to 45.49% in the highest concentration used (2 mg/mL), whereas Trolox (IC₅₀ = 0.34 mg/mL), as positive control, could reduce both compounds totally at the same concentration.

Figure 1: Dose-dependent inhibition of reactive oxygen species attack on salicylic acid by the C. cajucara aqueous extract (▲) and of Trolox (■), as positive control, in the HPLC-based hypoxanthine/xanthine oxidase assay (mean of 3 assays). DHBA: dihydroxybenzoic acid.

3.3. DPPH Scavenging Assay

The free radical scavenging effect of extracts, as well as ascorbic acid and rutin, both acting as positive controls, was tested using the DPPH free radical scavenging assay. The free radical scavenging effect of C. cajucara showed a concentration-dependent activity, based on a 91.38% inhibition at the concentration of 1000 g/mL and of 57.32% at 100 g/mL (Table 1). The respective IC₅₀ value for the extract was 63.34 g/mL. In comparison, the results of the free radical scavenging effect of ascorbic acid (IC₅₀ = 4.03 g/mL) and trolox (IC₅₀ = 15.52 g/mL) were respectively, 99.62% and 99.03% inhibition at the concentration of 1000 g/mL and 99.40% and 91.27% at 100 g/mL.

Table 1: Inhibition of DPPH, IC₅₀ values for the DPPH assay of the C. cajucara aqueous extract, Trolox, rutin, and ascorbic acid, as well as the AEAC**.

Sample
Inhibition (%)
IC₅₀ (μg/mL)

concentration
1 μg/mL
10 μg/mL
100 μg/mL
1000 μg/mL

Ascorbic acid
9.70
98.11
99.40
99.62
4.03 ± 0.16

Trolox
8.94
45.82
91.27
99.03
15.52 ± 2.64

Rutin
5.22
31.83
82.86
97.89
18.64 ± 0.94

C. cajucara
2.61
13.74
57.32
91.38
63.34 ± 29.28

Mean ± standard deviation of three individual determinations. Results were based on the values measured at 20 min. Ascorbic acid, vitamin E, and rutin were used as positive controls.

3.4. Biochemical Analysis and Oxidative Stress

C. cajucara administration failed to reduce glycemia in diabetic rats. The treatment with C. cajucara during 5 (DM5D) and 20 (DM20D) days significantly reduced the lipoperoxidation. Normal animals treated with the aqueous extract during 20 days (CO20D) had the lipoperoxidation increased, although significantly less than the diabetic animals. SOD activity was higher in diabetic animals if compared to the controls. This effect was partially abolished by administration of the bark extract. Animals that received only bark extract for 20 days (CO20D) also had SOD activity increased. However, activity of antioxidant enzyme CAT did not show any differences between the groups. GSH activity was significantly higher in liver. The treatment with C. cajucara during 5 days decreased significantly GSH activity (Table 2).

Table 2: Biochemical analyses of oxidative stress in liver tissue.

Group
TBARS (nmoles/mg of protein)
SOD (U/mg protein)
CAT (pmoles/mg protein)
GSH (nmoles/mg of protein)

CO
0.31 ± 0.04
2.38 ± 0.29
0.34 ± 0.04
4344.01 ± 433.64

CO5D
0.38 ± 0.06
3.39 ± 0.19
0.42 ± 0.07
5188.72 ± 233.98

CO20D
0.54 ± 0.05*
5.57 ± 0.67*
0.5 ± 0.07
4654.82 ± 480.51

DM
0.92 ± 0.05**
8.34 ± 1.05**
0.57 ± 0.05
2851.94 ± 378.76**

DM5D
0.55 ± 0.06***
4.14 ± 0.48***
0.49 ± 0.07
4094.46 ± 293.00***

DM20D
0.48 ± 0.08***
3.93 ± 0.44***
0.48 ± 0.08
3020.94 ± 151.43

CO: control (); CO5D: control treated with C. cajucara for 5 days (); CO20D: control treated with C. cajucara for 20 days (); DM: diabetes mellitus(); DM5D: diabetes mellitus treated with C. cajucara for 5 days (); DM20D: Diabetes Mellitus treated with C. cajucara for 20 days (). C. cajucara 5% aqueous extract.

Data appear as mean ± SEM.

* CO20D, versus CO, CO5D.

** DM versus CO, CO5D, CO20D, DM5D, DM20D.

*** DM versus CO, DM.

3.5. Western Blot for p65 NF-κB Subunit

To study the effects on p65 NF-κB subunit expression, liver nuclear extracts were studied by western blot. As shown in Figure 2  C. cajucara affects NF-κB binding activity in CO20D. Experimental diabetes markedly induced NF-κB, an effect that was abolished by C. cajucara treatment.

Figure 2: Effect of streptozotocin-induced diabetes and C. cajucara aqueous extract on liver in p65 NF-κB protein by Western blot analysis.

4. Discussion

The potential mechanism underlying the antioxidant property of C. cajucara extract was investigated using the in vitro assay hypoxanthine/xanthine oxidase, which revealed an expressive reduction in the concentration of DHBAs, the byproducts of the reaction between the hydroxyl radical and salicylic acid, as shown in Figure 1. Therefore, it can be suggested that the compounds present in C. cajucara extract may act as scavengers of the hydroxyl radical generated by the Haber-Weiss/Fenton reaction, acting as and/or OH• scavenger, and that the protection provided by extract is probably due to its ability to quench free radicals. Several plant extracts and secondary metabolites derived from plants show in vitro antioxidant activity by quenching hydroxyl radicals, evaluated using this assay [26]. In addition, the results of the antioxidant evaluation using DPPH reduction confirm the dose-response manner pattern of the antioxidant effect of this extract (Table 1). When the DPPH solution is mixed with some hydrogen donor compound, it is reduced to diphenylpicrylhydrazine and loses its violet color [27]. The degree of coloration loss bears a direct correlation with the activity of elimination of free radicals in the compound evaluated [28]. Several series of chemical compounds have been studied and presented a close correlation between DPPH sequestering activity and antioxidant activity in biological and nonbiological models [29, 30]. The differences of the C. cajucara extract IC₅₀ values for both antioxidant assays might be explained due to different antioxidant compounds responsible for radical-scavenging in both tests. Through of the phytochemical screening were detected alkaloids, flavonoids, and coumarins. Based on the antioxidant activity reported in the literature for alkaloids, flavonoids, and coumarins we can link the presence of these secondary metabolites to the antioxidant activity detected [31, 32].

Oxidative stress is produced under diabetic condition and it is likely to be involved in progression of pancreatic β-cell dysfunction [33]. High levels of free radicals, due to insufficiency of the antioxidant defense system, may lead to disruption of cellular function, oxidative damages to membranes, and enhance their susceptibility to lipoperoxidation [34]. In recent years, dietary plants with antioxidative property have been the center of focus. It is believed that these plants can prevent or protect tissues by antiobesity and hypoglycaemic effects [35]. The protection of hepatocyte cells from the effects of oxidative stress by treatment with vitamin E was evidenced in a recent study [36]. In addition, it has been shown that dietary supplementation with natural antioxidants such as vitamins C and E, melatonin, and flavonoids attenuates the oxidative stress and diabetic state induced by STZ [37, 38].

Increased levels of TBARS, an end-product of lipoperoxidation, were found previously in the liver of streptozotocin-induced diabetic rats [39–41]. In this study, the TBARS increase confirms this finding, which indicates an overall oxidative stress increase in diabetic rats. Treatment with C. cajucara bark extract suggests an amelioration of oxidative stress. trans-dehydrocrotonin (t-DCTN), the main component of the bark extract, showed hypoglycemic, anti-inflammatory, analgesic, antiulcerogenic, and antilipidemic effects [42].

Oxidative stress is the result of a redox imbalance between the generation of ROS and the compensatory response from the endogenous antioxidant network. Although some studies which measured activities of SOD, CAT, and glutathione peroxidase in diabetes mellitus showed reduction in the levels of theses enzymes [43], other authors reported an increase in SOD and CAT activities in streptozotocin-induced diabetic rats [44]. These apparently contradictory results could be due to tissue specificity, variation in severity and duration of the disease, or other experimental conditions. Hyperglycemia results in increased enzymatic conversion of glucose to the polyalcohol sorbitol with concomitant decreases in NADPH and glutathione [43, 45]. The resulting loss of antioxidant reducing equivalents results in enhanced sensitivity to oxidative stress associated with intracellular ROS. In the present study, SOD activity increased in diabetic rats. This effect may thus be an adaptive response for increased oxidative stress in the liver tissue; C. cajucara bark extract by scavenging ROS prevents the elevation of this antioxidant enzyme activities in diabetic rat liver. This suggests the possibility of a radical superoxide scavenger activity. In our study, CAT activity remained unchanged. One the consequences of hyperglycemia is increase the metabolism of glucose by sorbitol pathway. Besides this, other pathways, such as fatty acid and cholesterol biosynthesis, also compete for NADPH with GSH. We also observed the decreased in GSH in the liver of streptozotocin-induced diabetic rats. Under in vivo condition, GSH acts as an antioxidant and its decrease is reported in diabetes mellitus studies in [46]. showed that GSH level was significantly lower in diabetic rats than normal rats. In the present study we found that treatment with C. cajucara bark extract significantly increased the glutathione when compared to diabetic control rats where the levels were significantly decrease. This increased GSH in rats treated with C. cajucara bark for 5 days extract may be one of the factors responsible for the inhibition of lipoperoxidation.

The NF-κB has been proposed to form a critical bridge between oxidant stress and the cellular response [47, 48]. One mechanism by which hyperglycaemia-induced oxidative stress might alter cellular functions is activation of the transcription factor NF-κB [39]. Rodrigues et al. [49] showed than glucose concentration in the blood plasma of streptozotocin-treated rats was significantly higher than in the normal control group and in the animals treated with C. cajucara. In our study, to evaluate the liver tissue of diabetic animals found significant increase in the activation of NF-κB. In contrast, the treatment with C. cajucara prevented NF-κB activation [49]. However, a significant increase in oxidative stress and in the expression of p65 NF-κB was found in the group that underwent treatment for 20 days. Although the previous study did not demonstrate genotoxic effects using the same period, other studies show reports of fulminant hepatitis related to the indiscriminate use of the plant [50].

In summary, the results show that in situations where there is no oxidative stress the extended use of C. cajucara behaves acts as a prooxidant and in situations where there is oxidative stress the treatment with C. cajucara may be an antioxidant scavenger of free radicals. Furthermore, the results seem to support the hypothesis that the oxidative stress in DM stimulates NF-κB expression and that C. cajucara aqueus extract administration reduces this expression.

Acknowledgments

This study was supported by the CAPES and FIPE (Financiamento de pesquisas do Hospital de Clínicas de Porto Alegre).

References

American Diabetes Association, “Standards of care for diabetes,” Diabetes Care, vol. 17, no. 12, pp. 1514–1522, 1994.

J. S. Johansen, A. K. Harris, D. J. Rychly, and A. Ergul, “Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical pratice,” Cardiovascular Diabetology, vol. 4, article 5, 2005.

L. Pari and R. Saravanan, “Beneficial effect of succinic acid monoethyl ester on erythrocyte membrane bound enzymes and antioxidant status in streptozotocin-nicotinamide induced type 2 diabetes,” Chemico-Biological Interactions, vol. 169, no. 1, pp. 15–24, 2007.

A. C. Maritim, R. A. Sanders, and J. B. Watkins, “Effects of α-lipoic acid on biomarkers of oxidative stress in streptozotocin-induced diabetic rats,” Journal of Nutritional Biochemistry, vol. 14, no. 5, pp. 288–294, 2003.

G. Baydas, H. Canatan, and A. Turkoglu, “Comparative analysis of the protective effects of melatonin and vitamin E on streptozocin-induced diabetes mellitus,” Journal of Pineal Research, vol. 32, no. 4, pp. 225–230, 2002.

J. L. Evans, I. D. Goldfine, B. A. Maddux, and G. M. Grodsky, “Are oxidative stress—activated signaling pathways mediators of insulin resistance and β-cell dysfunction?” Diabetes, vol. 52, no. 1, pp. 1–8, 2003.

S. Schiekofer, G. Galasso, M. Andrassy, T. Aprahamian, J. Schneider, and E. Rocnik, “Glucose control with insulin results in reduction of NF-κB-binding activity in mononuclear blood cells of patients with recently manifested type 1 diabetes,” Diabetes, Obesity and Metabolism, vol. 8, no. 5, pp. 473–482, 2006.

M. J. Moshi, “Current and future prospects of integrating traditional and alternative medicine in the management of diseases in Tanzania,” Tanzania Health Research Bulletin, vol. 7, no. 3, pp. 159–167, 2005.

M. E. Van Den Berg, Plantas Medicinais na Amazônia—Contribuição ao seu Conhecimento Sistemático, 1982

L. C. Di Stasi, E. M. G. Santos, and C. M. Santos, Hiruma-Lima CA. Plantas Medicinais da Amazônia, 1989

A. M. Luna Costa, J. C. Silva, A. R. Campos, V. S. Rao, and M. A. Maciel, “Pinto AC Antioestrogenic effect of trans-dehydrocrotonin, a nor-clerodane diterpene from Croton cajucara Benth in rats,” Phytotherapy Research Journal, vol. 13, pp. 689–691, 1999.

M. Tieppo, M. Porawski, M. Salvador et al., “Croton cajucara BENTH. Leaf extract scavenges the stable free radical DPPH and protects against oxidative stress induced by paraquat,” Biological and Pharmaceutical Bulletin, vol. 29, no. 1, pp. 161–165, 2006.

A. Dey and K. Swaminathan, “Hyperglycemia-induced mitochondrial alterations in liver,” Life Sciences, vol. 87, no. 7-8, pp. 197–214, 2010.

J. B. Harbone, Phytochemical Methods, Clarendon Press, Oxford, UK, 1998.

H. Wagner and S. Bladt, Plant Drug Analysis: A Thin Layer Chromatography Atlas, Springer, Berlin, Germany, 1996.

R. W. Owen, T. Wimonwatwatee, B. Spiegelhalder, and H. Bartsch, “A high performance liquid chromatography system for quantification of hydroxyl radical formation by determination of dihydroxy benzoic acids,” European Journal of Cancer Prevention, vol. 5, no. 4, pp. 233–240, 1996.

R. W. Owen, A. Giacosa, W. E. Hull, R. Haubner, B. Spiegelhalder, and H. Bartsch, “The antioxidant/anticancer potential of phenolic compounds isolated from olive oil,” European Journal of Cancer, vol. 36, no. 10, pp. 1235–1247, 2000.

R. W. Owen, R. Haubner, W. Mier et al., “Isolation, structure elucidation and antioxidant potential of the major phenolic and flavonoid compounds in brined olive drupes,” Food and Chemical Toxicology, vol. 41, no. 5, pp. 703–717, 2003.

T. Yamaguchi, H. Takamura, T. Matoba, and J. Terao, “HPLC method for evaluation of the free radical-scavenging activity of foods by using 1,1-Diphenyl-2-picrylhydrazyl,” Bioscience, Biotechnology and Biochemistry, vol. 62, no. 6, pp. 1201–1204, 1998.

O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, “Protein measurement with the Folin phenol reagent,” The Journal of Biological Chemistry, vol. 193, no. 1, pp. 265–275, 1951.

J. A. Buege and S. D. Aust, “Microsomal lipid peroxidation,” Methods in Enzymology, vol. 52, pp. 302–310, 1978.

H. P. Misra and I. Fridovich, “The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase,” Journal of Biological Chemistry, vol. 247, no. 10, pp. 3170–3175, 1972.

A. Boveris and B. Chance, “The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen,” Biochemical Journal, vol. 134, no. 3, pp. 707–716, 1973.

A. Kolberg, T. G. Rosa, M. T. Puhl et al., “Low expression of MRP1/GS-X pump ATPase in lymphocytes of Walker 256 tumour-bearing rats is associated with cyclopentenone prostaglandin accumulation and cancer immunodeficiency,” Cell Biochemistry and Function, vol. 24, no. 1, pp. 23–39, 2006.

M. B. Gutiérrez, B. S. Miguel, C. Villares, J. G. Gallego, and M. J. Tuñón, “Oxidative stress induced by Cremophor EL is not accompanied by changes in NF-κB activation or iNOS expression,” Toxicology, vol. 222, no. 1-2, pp. 125–131, 2006.

M. F. Richter, J. M. Boeira, D. J. Moura, J. A. P. Henriques, and J. Saffi, “Antioxidant properties of β-carboline alkaloids are related to their antimutagenic and antigenotoxic activities,” Mutagenesis, vol. 22, no. 4, pp. 293–302, 2007.

D. G. Soares, A. C. Andreazza, and M. Salvador, “Sequestering ability of butylated hydroxytoluene, propyl gallate, resveratrol, and vitamins C and E against ABTS, DPPH, and hydroxyl free radicals in chemical and biological systems,” Journal of Agricultural and Food Chemistry, vol. 51, no. 4, pp. 1077–1080, 2003.

J. Lehuédé, B. Fauconneau, L. Barrier, M. Ourakow, A. Piriou, and J. M. Vierfond, “Synthesis and antioxidant activity of new tetraarylpyrroles,” European Journal of Medicinal Chemistry, vol. 34, no. 11, pp. 991–996, 1999.

K. Hussain, Z. Ismail, A. Sadikun, and P. Ibrahim, “Antioxidant, anti-TB activities, phenolic and amide contents of standardised extracts of Piper sarmentosum Roxb,” Natural Product Research, vol. 23, no. 3, pp. 238–249, 2009.

E. V. Costa, M. L. B. Pinheiro, A. Barison et al., “Alkaloids from the bark of Guatteria hispida and their evaluation as antioxidant and antimicrobial agents,” Journal of Natural Products, vol. 73, no. 6, pp. 1180–1183, 2010.

G. M. Nardi, R. Felippi, S. DalBó et al., “Anti-inflammatory and antioxidant effects of Croton celtidifolius bark,” Phytomedicine, vol. 10, no. 2-3, pp. 176–184, 2003.

H. Nazemiyeh, E. M. Kazemi, K. Zare, M. Jodari, L. Nahar, and S. D. Sarker, “Free radical scavengers from the aerial parts of Euphorbia petiolata,” Journal of Natural Medicines, vol. 64, no. 2, pp. 187–190, 2010.

Y. Kajimoto and H. Kaneto, “Role of oxidative stress in pancreatic β-cell dysfunction,” Annals of the New York Academy of Sciences, vol. 1011, pp. 168–176, 2004.

J. W. Baynes, “Role of oxidative stress in development of complications in diabetes,” Diabetes, vol. 40, no. 4, pp. 405–412, 1991.

F. Rivera-Ramírez, G. N. Escalona-Cardoso, L. Garduño-Siciliano, C. Galaviz-Hernández, and N. Paniagua-Castro, “Antiobesity and hypoglycaemic effects of aqueous extract of Ibervillea sonorae in mice fed a high-fat diet with fructose,” Journal of Biomedicine and Biotechnology, vol. 2011, Article ID 968984, 6 pages, 2011.

J. H. Tsai, H. W. Chen, Y. W. Chen, J. Y. Liu, and C. K. Lii, “The protection of hepatocyte cells from the effects of oxidative stress by treatment with vitamin e in conjunction with DTT,” Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 486267, 2010.

O. Coskun, M. Kanter, A. Korkmaz, and S. Oter, “Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and β-cell damage in rat pancreas,” Pharmacological Research, vol. 51, no. 2, pp. 117–123, 2005.

M. A. M. Maciel, A. C. Pinto, A. C. Arruda et al., “Ethnopharmacology, phytochemistry and pharmacology: a successful combination in the study of Croton cajucara,” Journal of Ethnopharmacology, vol. 70, no. 1, pp. 41–55, 2000.

A. S. Dias, M. Porawski, M. Alonso, N. Marroni, P. S. Collado, and J. González-Gallego, “Quercetin decreases oxidative stress, NF-κB activation, and iNOS overexpression in liver of streptozotocin-induced diabetic rats,” Journal of Nutrition, vol. 135, no. 10, pp. 2299–2304, 2005.

F. C. Di Naso, A. Simoes Dias, M. Porawski, and N. A. P. Marroni, “Exogenous superoxide dismutase: action on liver oxidative stress in animals with streptozotocin-induced diabetes,” Experimental Diabetes Research, vol. 2011, Article ID 754132, 6 pages, 2011.

F. C. Di Naso, R. N. de Mello, S. Bona et al., “Effect of Agaricus blazei Murill on the pulmonary tissue of animals with streptozotocin-induced diabetes,” Experimental diabetes research, vol. 2010, Article ID 543926, 8 pages, 2010.

R. M. Silva, F. A. Santos, V. S. N. Rao, M. A. Maciel, and A. C. Pinto, “Blood glucose- and triglyceride-lowering effect of trans-dehydrocrotonin, a diterpene from Croton cajucara benth., in rats,” Diabetes, Obesity and Metabolism, vol. 3, no. 6, pp. 452–456, 2001.

R. A. Sanders, F. M. Rauscher, and J. B. Watkins, “Effects of Quercetin on antioxidant defense in streptozotocin-induced diabetic rats,” Journal of Biochemical and Molecular Toxicology, vol. 15, no. 3, pp. 143–149, 2001.

S. Y. Cho, J. Y. Park, E. M. Park et al., “Alternation of hepatic antioxidant enzyme activities and lipid profile in streptozotocin-induced diabetic rats by supplementation of dandelion water extract,” Clinica Chimica Acta, vol. 317, no. 1-2, pp. 109–117, 2002.

M. Vijayakumar, R. Govindarajan, G. M. M. Rao et al., “Action of Hygrophila auriculata against streptozotocin-induced oxidative stress,” Journal of Ethnopharmacology, vol. 104, no. 3, pp. 356–361, 2006.

U. Chakraborty and H. Das, “Antidiabetic and antioxidant activities of cinnamomum tamala leaf extracts in Stz-Treated diabetic rats,” Global Journal of Biotechnology & Biochemistry, vol. 5, pp. 12–18, 2010.

P. J. Barnes and M. Karin, “Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases,” The New England Journal of Medicine, vol. 336, no. 15, pp. 1066–1071, 1997.

E. Maioli, L. Greci, K. Soucek et al., “Rottlerin inhibits ROS formation and prevents NFB activation in MCF-7 and HT-29 cells,” Journal of Biomedicine and Biotechnology, vol. 2009, Article ID 742936, 7 pages, 2009.

G. Rodrigues, E. Marcolin, S. Bona, M. Porawski, M. Lehmann, and N. P. Marroni, “Hepatics alterations and genotoxic effects of Croton cajucara Benth (SACACA) in diabetic rats,” Arquivos de Gastroenterologia, vol. 47, no. 3, pp. 301–305, 2010.

A. R. Agner, M. A. Maciel, A. C. Pinto, S. G. Pamplona, I. M. Colus, and I. M. Cólus, “Investigation of genotoxic activity of transdehydrocrotonin, a clerodane diterpene from Croton cajucara,” Teratog Carcinog Mutagen, vol. 19, pp. 377–384, 1999.